Trillium Group

Omni-ID is a leading supplier of passive low-profile UHF RFID tags. The company is focused on delivering affordable high-performance tags that work reliably in harsh environments-including metals and liquids. Omni-ID technology affords customers complete accuracy in the identification and management of high value assets.

Omni-ID is a leading supplier of passive low-profile UHF RFID tags. The company is focused on delivering affordable high-performance tags that work reliably in harsh environments-including metals and liquids. Omni-ID technology affords customers complete accuracy in the identification and management of high value assets.

OyaGen, Inc. is a biotechnology company based in Rochester, New York, established in 2003. The company specializes in the discovery, development, and commercialization of pharmaceutical therapies that leverage RNA and DNA editing enzymes. Its innovative platform technology focuses on editing enzymes that can influence a variety of biological functions, including antiviral responses, cancer treatment, immunoglobulin gene rearrangements, inflammation, ion channel activity, LDL reduction, neuro-cognitive functions, and the expression of red blood cells in the fetal liver. By chemically altering RNA or DNA molecules, OyaGen aims to provide enhanced therapeutic options for conditions such as human immunodeficiency virus and other diseases.

ClearMomentum, Inc. offers financial reporting software tailored for venture capital and private equity investors, boards, and limited partners. Founded in 2005 and headquartered in Canandaigua, New York, the company developed the first private equity portfolio management solution designed to streamline the collection, analysis, reporting, and distribution of portfolio company data. Its flagship product, ClearFinancials, serves as a portfolio monitoring application that validates and synthesizes private company financial statements while facilitating collaboration through a web portal for sharing investment documents and creating custom workflows. Additionally, ClearMomentum provides an iPad application that allows users to monitor financial metrics, access historical data, and personalize their dashboards. The company addresses critical issues in data management and reporting by offering a structured data warehouse to archive disparate documents securely. ClearMomentum’s solutions aim to enhance data transparency, accuracy, and timeliness for alternative asset investors, thereby improving efficiency in portfolio company financial reporting.

iCardiac Technologies, Inc. develops cardiac safety biomarkers. The company offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers that delivers assessment of the cardiac safety profile of drugs in development. Its technology is used in cardiac clinical trials conducted by pharmaceutical, biotechnology, and medical device companies. The company’s services include scientific and medical consultation, study design, data and project management, ECG analysis, statistical reporting, data submission, and interface with the regulators. iCardiac Technologies, Inc. was founded in 2006 and is headquartered in Rochester, New York.

Communication Synergy Technologies Inc., a Rochester, N.Y.–based developer of document management solutions.

Appairent Technologies, Inc. is a wireless multimedia systems and solutions company that provides radio modules, software and intellectual property to major consumer-electronics manufacturers. Their products - based on industry standards - employ cutting-edge technology to deliver low-power and low-cost streaming multimedia applications, from digital cameras and personal data assistants, to televisions, set-top boxes, MP3 players, laptop computers, digital camcorders and more. Appairent Technologies was formed - and is operated - by experienced consumer-electronics experts, including leaders of the IEEE 802.15 working group and an original co-founder of the 802.11 working group. They're proud to be a member of the IEEE-standards activities and a founding member of the WiMedia Alliance. Appairent Technologies spun off as an independent company from Eastman Kodak Company in January 2002.

VirtualScopics, Inc. specializes in providing imaging services tailored for the pharmaceutical, biotechnology, and medical device sectors, particularly during clinical trials. The company develops a range of image analysis software tools and applications that facilitate the detection and measurement of specific anatomical structures and metabolic activity through medical imaging. Its proprietary technology enables accurate and reproducible assessments of subtle changes in anatomical structures associated with diseases such as oncology, cardiology, neurology, and musculoskeletal disorders. Additionally, VirtualScopics has established strategic partnerships to enhance its offerings, including collaborations with PPD Development, IXICO, and Micron to provide integrated solutions for clinical development and imaging needs across various therapeutic areas. Founded in 1988 and headquartered in Rochester, New York, the company operates as a subsidiary of BioTelemetry, Inc. since 2016.